You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 45 No. 7, July 1988 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Intracerebral Inoculation of Experimental Animals With Brain Tissue From Patients With Schizophrenia

Failure to Observe Consistent or Specific Behavioral and Neuropathological Effects

Charles A. Kaufmann, MD; Daniel R. Weinberger, MD; Janice R. Stevens, MD; David M. Asher, MD; Joel E. Kleinman, MD, PhD; Michael P. Sulima; Clarence J. Gibbs, Jr, PhD; D. Carleton Gajdusek, MD

Arch Gen Psychiatry. 1988;45(7):648-652.


Abstract



• To test the possibility that some cases of schizophrenia result from infection with a transmissible slow viral agent, 57 experimental animals (six chimpanzees, 12 Old World monkeys, 17 New World monkeys, and 22 guinea pigs) were inoculated intracerebrally with brain tissue from ten patients and followed up for six years. Behavioral comparisons with control animals revealed no consistent behavioral differences. Histological, immunohistochemical, and morphometric examination of brains of animals that died revealed no specific neuropathological abnormalities. These findings do not support a role for a virus-induced slow infection in the pathogenesis of schizophrenia but must be weighed against methodological limitations in animal susceptibility, disease communicability, and assay sensitivity.



Author Affiliations



From the Neuropsychiatry Branch (Drs Kaufmann and Stevens) and Clinical Brain Disorders Branch (Drs Weinberger and Kleinman), Intramural Research Program, St Elizabeths Hospital, National Institute of Mental Health, Washington, DC; and the Laboratory of Central Nervous System Studies (Drs Kaufmann, Asher, Gibbs, and Gajdusek and Mr Sulima), National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD.


Footnotes



Accepted for publication June 15, 1987.

Reprint requests to Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, William A. White Building, St Elizabeths Hospital, Washington, DC 20032 (Dr Weinberger).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Search for Viral Nucleic Acid Sequences in Brain Tissues of Patients With Schizophrenia Using Nested Polymerase Chain Reaction
Taller et al.
Arch Gen Psychiatry 1996;53:32-40.
ABSTRACT  

Viruses and Schizophrenia
O'Reilly
Aust N Z J Psychiatry 1994;28:222-228.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.